Different angiogenic CXC chemokine levels in bronchoalveolar lavage fluid after interferon gamma-1b therapy in idiopathic pulmonary fibrosis patients
- 31 December 2008
- journal article
- Published by Elsevier in Pulmonary Pharmacology & Therapeutics
- Vol. 21 (6) , 840-844
- https://doi.org/10.1016/j.pupt.2008.06.005
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Clinical Year in Review II: Interstitial Lung Disease, Sepsis, Pulmonary Infections, and Sleep MedicineProceedings of the American Thoracic Society, 2007
- Active Remodeling in Idiopathic Interstitial Pneumonias: Evaluation of Collagen Types XII and XIVJournal of Histochemistry & Cytochemistry, 2006
- Long-term clinical effects of interferon gamma-1b and colchicine in idiopathic pulmonary fibrosisEuropean Respiratory Journal, 2006
- Current and future therapeutic approaches in idiopathic pulmonary fibrosisEuropean Respiratory Journal, 2005
- CXC chemokines in angiogenesisCytokine & Growth Factor Reviews, 2005
- Angiogenic cytokines in patients with idiopathic interstitial pneumoniaThorax, 2004
- Interferon-γ: an overview of signals, mechanisms and functionsJournal of Leukocyte Biology, 2003
- Elevated Serum Levels of the CXCR3 Chemokine ITAC Are Associated With the Development of Transplant Coronary Artery DiseaseCirculation, 2003
- A Preliminary Study of Long-Term Treatment with Interferon Gamma-1b and Low-Dose Prednisolone in Patients with Idiopathic Pulmonary FibrosisNew England Journal of Medicine, 1999
- Precapillary Systemic-pulmonary AnastomosesThorax, 1963